论文部分内容阅读
目的:观察黄芪注射液合生脉注射液治疗急性病毒性心肌炎的临床疗效。方法:将80例急性病毒性心肌炎患者按3:1分为治疗组60例和对照组20例,对照组采用西药常规治疗,治疗组在对照组用药基础上加用黄芪注射液合生脉注射液静脉滴注,观察两组疗效和心电图变化。结果:治疗组总有效率93.33%,对照组总有效率65.00%,治疗组疗效明显优于对照组(P<0.01);心电图方面,治疗组心电图明显改善(P<0.01)、心律失常改善(P<0.05)。结论:黄芪注射液合生脉注射液是佐治急性病毒性心肌炎的有效药物,能明显改善异常心电图。
Objective: To observe the clinical efficacy of Astragalus injection and Shengmai injection in the treatment of acute viral myocarditis. Methods: Eighty patients with acute viral myocarditis were divided into treatment group (60 cases) and control group (20 cases) according to the ratio of 3: 1. The control group was treated with western medicine routinely. The treatment group was given astragalus injection combined with Shengmai injection Intravenous drip, observe the two groups efficacy and ECG changes. Results: The total effective rate was 93.33% in the treatment group and 65.00% in the control group, and the curative effect in the treatment group was significantly better than that in the control group (P <0.01); in the electrocardiogram, the electrocardiogram was significantly improved (P <0.01) and the arrhythmia was improved P <0.05). Conclusion: Astragalus injection combined with Shengmai injection is an effective drug for treating acute viral myocarditis, which can obviously improve abnormal ECG.